HighTower Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,490
Closed -$37.4K 3997
2025
Q3
$37.4K Buy
7,490
+1,509
+25% +$6.99K ﹤0.01% 3630
2025
Q2
$28.2K Sell
5,981
-505
-8% -$2.21K ﹤0.01% 3590
2025
Q1
$29.8K Sell
6,486
-5,012
-44% -$23.4K ﹤0.01% 3493
2024
Q4
$55.1K Buy
11,498
+6,017
+110% +$28.9K ﹤0.01% 3447
2024
Q3
$26K Sell
5,481
-999
-15% -$5.36K ﹤0.01% 3488
2024
Q2
$37K Buy
+6,480
New +$33.5K ﹤0.01% 3339
2024
Q1
Sell
-73,750
Closed -$315K 4040
2023
Q4
$315K Buy
73,750
+5,532
+8% +$22.3K ﹤0.01% 2672
2023
Q3
$298K Buy
68,218
+55,955
+456% +$311K ﹤0.01% 2604
2023
Q2
$80K Buy
+12,263
New +$78.6K ﹤0.01% 3114
2019
Q1
Sell
-9,539
Closed -$249K 2437
2018
Q4
$249K Sell
9,539
-113
-1% -$2.66K ﹤0.01% 1710
2018
Q3
$221K Buy
+9,652
New +$197K ﹤0.01% 1899

Other funds holding VNDA